Acapella Versus Lung Flute in Treatment of COPD Patients the Study Aims to Identify the Preference Between the Two Devices According to Treatment of COPD Patients Regarding Pulmonary Function Tests , Exercise Tolerence and Quality of Life Questionnaire,

Phase

N/A

Condition

Chronic Obstructive Pulmonary Disease (Copd)

Chronic Bronchitis

Chronic Obstructive Lung Disease

Treatment

Lung flute

Acapella

Clinical Study ID

NCT06801106

P.T.REC/012/002208

Ages 40-60
Male

Study Summary

Chronic obstructive pulmonary disease (COPD) is a prevalent and progressive condition characterized by persistent airflow limitation and chronic respiratory symptoms. Among the many approaches to managing COPD, airway clearance techniques (ACTs) play a pivotal role in improving pulmonary function, reducing symptoms, and enhancing quality of life. So, this study aimed to investigate the comparative efficacy of two ACT devices-the Acapella® and the Lung Flute®- on improving pulmonary function, exercise capacity, and quality of life in COPD patients.

The Acapella® and the Lung Flute®. Both devices utilize distinct mechanisms to facilitate mucus clearance and improve lung function. The Acapella® combines positive expiratory pressure (PEP) with oscillatory vibration, aiding in the loosening and mobilization of mucus . On the other hand, the Lung Flute® generates low-frequency sound waves through patient exhalation, stimulating mucus movement from the peripheral to central airways . While both devices have demonstrated efficacy in previous studies, there is limited comparative research evaluating their impact in COPD patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Moderate and mild severe COPD patients were selected according GOLD guidelines.
All patients were diagnosed as COPD with chronic bronchitis for at least two years.
All Patients were using their prescribed medications including Broncho-dilators andmucolytics.
Patients ceased smoking 2 months before undergoing the study.
Patients were selected of BMI between 25-34.9.

Exclusion

Exclusion Criteria:

• History of osteoporosis, significant gastro-esophageal reflux, hiatus hernia.
Recent acute cardiac event (6 weeks) or congestive cardiac failure.
Any significant musculoskeletal disorders.
Presence of active hemoptysis.
Presence of malignant disease.
Patients undergoing exacerbations.
Patients of hospital admission in last 6 month.
Patients with cough, rhonchi, and expectoration in last 6 month.
Patients who undergo exertional desaturation of oxygen below 90% after 6MWT.
Patients who suffer from prolonged recovery time of HR for more than one minuteafter finishing 6MWT.
Prolonged recovery time of heart rate <1 min.
Patients who cannot walk.

Study Design

Lung flute

January 31, 2021

January 20, 2024

Study Description

A controlled randomized study having 70 individuals with COPD was conducted. Before the treatment began, all participants signed a permission after being informed about the study's specifics and their rights as patients. The Ethics Committee Board of Cairo University's Faculty of Physical Therapy authorized this study (P.T.REC/012/002208). The research was done in accordance with the Helsinki 0 male COPD patients aged 40-60 years, recruited from Kasr Al Ainy Hospital, Cairo University. Participants were diagnosed with moderate to severe COPD and were randomly assigned into two groups: Group A received Acapella® therapy alongside standard chest physiotherapy, and Group B received Lung Flute® therapy with the same physiotherapy protocol. Both groups underwent interventions every other day for eight weeks. Outcomes were assessed using pulmonary function tests (PFTs), the six-minute walk test (6MWT), and the VQ11 quality-of-life questionnaire.

Connect with a study center

Cairo University
Cairo, 11432
Egypt
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.